<SEC-DOCUMENT>0001654954-17-007769-index.html : 20170818 <SEC-HEADER>0001654954-17-007769.hdr.sgml : 20170818 <ACCEPTANCE-DATETIME>20170818172127 ACCESSION NUMBER: 0001654954-17-007769 CONFORMED SUBMISSION TYPE: S-1 PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20170818 DATE AS OF CHANGE: 20170818 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: S-1 SEC ACT: 1933 Act SEC FILE NUMBER: 333-220061 FILM NUMBER: 171041722 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 </SEC-HEADER> <DOCUMENT> <TYPE>S-1 <SEQUENCE>1 <FILENAME>cvm_s1.htm <DESCRIPTION>PRIMARY DOCUMENT <TEXT> Document 1 - file: cvm_s1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5 <SEQUENCE>2 <FILENAME>cvm_ex5.htm <DESCRIPTION>OPINION ON LEGALITY <TEXT> Document 2 - file: cvm_ex5.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>cvm_ex231.htm <DESCRIPTION>CONSENTS OF EXPERTS AND COUNSEL <TEXT> Document 3 - file: cvm_ex231.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.2 <SEQUENCE>4 <FILENAME>cvm_ex232.htm <DESCRIPTION>CONSENTS OF EXPERTS AND COUNSEL <TEXT> Document 4 - file: cvm_ex232.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>cvm_s1000.jpg <DESCRIPTION>IMAGE <TEXT> Document 5 - file: cvm_s1000.jpg
</DOCUMENT> </SEC-DOCUMENT>